Pfizer (PFE.US) and BioNTech (BNTX.US) released upbeat news regarding vaccine
Major indices rose sharply on Wednesday after Pfizer (PFE.US) and BioNTech (BNTX.US) confirmed that three vaccine doses neutralize Omicron variant, while two-dose vaccine may still prevent severe disease. Also both companies said, that Omicron variant-specific vaccine could be available by March
Right after the publication of this information, we can observe a positive reaction from risky assets. In the meantime, there have also been reports of new restrictions in the UK, but it seems that at the moment they are being ignored by the market.
āđāļĢāļīāđāļĄāđāļāļĢāļāļāļąāļāļāļĩāļ§āļąāļāļāļĩāđ āļŦāļĢāļ·āļ āļĨāļāļāđāļāđāļāļąāļāļāļĩāļāļāļĨāļāļāđāļāļāđāļĢāđāļāļ§āļēāļĄāđāļŠāļĩāđāļĒāļ
āđāļāļīāļāļāļąāļāļāļĩ āļĨāļāļāļāļąāļāļāļĩāđāļāđāļĄāđ āļāļēāļ§āļāđāđāļŦāļĨāļāđāļāļāļĄāļ·āļāļāļ·āļ āļāļēāļ§āļāđāđāļŦāļĨāļāđāļāļāļĄāļ·āļāļāļ·āļGerman DAX (DE30), similarly to other European indices and US contracts moved higher and the price is getting closer to yesterday's highs. On the other hand, if reports regarding vaccine efficacy provoked only a temporary response, the key support is located around 15,663 points, which is marked with the lower limit of the 1: 1 structure and 23.6% Fibonacci retracement of the last upward wave.
DE30, M15 interval. Source:xStation5
